These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 35312980)

  • 1. Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Salivary Glands.
    Skálová A; Hyrcza MD; Leivo I
    Head Neck Pathol; 2022 Mar; 16(1):40-53. PubMed ID: 35312980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salivary Mucinous Adenocarcinoma Is a Histologically Diverse Single Entity With Recurrent AKT1 E17K Mutations: Clinicopathologic and Molecular Characterization With Proposal for a Unified Classification.
    Rooper LM; Argyris PP; Thompson LDR; Gagan J; Westra WH; Jordan RC; Koutlas IG; Bishop JA
    Am J Surg Pathol; 2021 Oct; 45(10):1337-1347. PubMed ID: 33739781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Salivary gland tumors: 2022 WHO blue book and beyond].
    Lépine C
    Ann Pathol; 2024 May; 44(3):175-182. PubMed ID: 38448262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the 2022 WHO Classification of Thyroid Neoplasms.
    Baloch ZW; Asa SL; Barletta JA; Ghossein RA; Juhlin CC; Jung CK; LiVolsi VA; Papotti MG; Sobrinho-Simões M; Tallini G; Mete O
    Endocr Pathol; 2022 Mar; 33(1):27-63. PubMed ID: 35288841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New information about tumours of the salivary glands : WHO classification 2022].
    Ihrler S; Jurmeister P; Haas C; Greber L; Agaimy A
    Pathologie (Heidelb); 2023 Jul; 44(4):214-223. PubMed ID: 37264269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland.
    Seethala RR; Stenman G
    Head Neck Pathol; 2017 Mar; 11(1):55-67. PubMed ID: 28247227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update of newly-recognized salivary gland neoplasms: molecular and immunohistochemical findings and clinical importance.
    Wolk RA; Cipriani NA
    Histopathology; 2024 Aug; ():. PubMed ID: 39108216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newly Described Entities in Salivary Gland Pathology.
    Skálová A; Gnepp DR; Lewis JS; Hunt JL; Bishop JA; Hellquist H; Rinaldo A; Vander Poorten V; Ferlito A
    Am J Surg Pathol; 2017 Aug; 41(8):e33-e47. PubMed ID: 28614209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in salivary gland pathology.
    Cheuk W; Chan JK
    Histopathology; 2007 Jul; 51(1):1-20. PubMed ID: 17539914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Molecular Testing in the Differential Diagnosis of Salivary Gland Carcinomas.
    Skálová A; Stenman G; Simpson RHW; Hellquist H; Slouka D; Svoboda T; Bishop JA; Hunt JL; Nibu KI; Rinaldo A; Vander Poorten V; Devaney KO; Steiner P; Ferlito A
    Am J Surg Pathol; 2018 Feb; 42(2):e11-e27. PubMed ID: 29076877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Decline of Salivary Adenocarcinoma Not Otherwise Specified as a Tumor Entity: Reclassification Using Contemporary Immunohistochemical Profiling and Diagnostic Criteria.
    Rooper LM; Mansour M; Yonescu R; Oliai BR; Bishop JA; Westra WH
    Am J Surg Pathol; 2021 Jun; 45(6):753-764. PubMed ID: 33284193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic Classification and Molecular Signature of Polymorphous Adenocarcinoma (PAC) and Cribriform Adenocarcinoma of Salivary Gland (CASG): An International Interobserver Study.
    Xu B; Barbieri AL; Bishop JA; Chiosea SI; Dogan S; Di Palma S; Faquin WC; Ghossein R; Hyrcza M; Jo VY; Lewis JS; Lozada JR; Michal M; Pareja FG; Perez-Ordonez B; Prasad ML; Purgina B; Reis-Filho JS; Scognamiglio T; Sebastiao APM; Seethala RR; Skálová A; Smith SM; Tekkeşin MS; Thompson LDR; Wasseman JK; Wenig BM; Weinreb I; Katabi N
    Am J Surg Pathol; 2020 Apr; 44(4):545-552. PubMed ID: 31917707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proceedings of the North American Society of Head and Neck Pathology Companion Meeting, New Orleans, LA, March 12, 2023: Classification of Salivary Gland Tumors: Remaining Controversial Issues?
    Skalova A; Hyrcza MD
    Head Neck Pathol; 2023 Jun; 17(2):285-291. PubMed ID: 37184732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKX3.1 Expression and Molecular Characterization of Secretory Myoepithelial Carcinoma (SMCA): Advancing the Case for a Salivary Mucous Acinar Phenotype.
    Patel S; Wald AI; Bastaki JM; Chiosea SI; Singhi AD; Seethala RR
    Head Neck Pathol; 2023 Jun; 17(2):467-478. PubMed ID: 36746884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SOX10-positive salivary gland tumors: a growing list, including mammary analogue secretory carcinoma of the salivary gland, sialoblastoma, low-grade salivary duct carcinoma, basal cell adenoma/adenocarcinoma, and a subgroup of mucoepidermoid carcinoma.
    Hsieh MS; Lee YH; Chang YL
    Hum Pathol; 2016 Oct; 56():134-42. PubMed ID: 27327192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsecretory Adenocarcinoma: A Novel Salivary Gland Tumor Characterized by a Recurrent MEF2C-SS18 Fusion.
    Bishop JA; Weinreb I; Swanson D; Westra WH; Qureshi HS; Sciubba J; MacMillan C; Rooper LM; Dickson BC
    Am J Surg Pathol; 2019 Aug; 43(8):1023-1032. PubMed ID: 31094920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newly described salivary gland tumors.
    Skalova A; Michal M; Simpson RH
    Mod Pathol; 2017 Jan; 30(s1):S27-S43. PubMed ID: 28060365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The myoepithelial immunophenotype in 135 benign and malignant salivary gland tumors other than pleomorphic adenoma.
    Prasad AR; Savera AT; Gown AM; Zarbo RJ
    Arch Pathol Lab Med; 1999 Sep; 123(9):801-6. PubMed ID: 10458827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SS18 Break-Apart Fluorescence In Situ Hybridization is a Practical and Effective Method for Diagnosing Microsecretory Adenocarcinoma of Salivary Glands.
    Bishop JA; Koduru P; Veremis BM; Oliai BR; Weinreb I; Rooper LM; Dickson BC; Demicco EG
    Head Neck Pathol; 2021 Sep; 15(3):723-726. PubMed ID: 33394377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microsecretory Adenocarcinoma of Salivary Glands.
    Bishop JA; Sajed DP
    Adv Anat Pathol; 2023 Mar; 30(2):130-135. PubMed ID: 36729381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.